Summary Report on Financial Results for the First Quarter of the Year Ending March 31st, 2022
(Japan GAAP)
July 30th, 2021
Stock Listing: TSE-JASDAQ
Company name:
Fukuda Denshi Co., Ltd.
Code No.:
6960 (http://www.fukuda.co.jp)
Representative:
Daijiro Shirai, President & COO
Inquiries:
Haruhiko Honbu, Senior Manager of Accounting & Finance DepartmentTel:+81-3-5684-1558 (main)
Scheduled date for filing the quarterly report:
August 6th, 2021
Scheduled date for commencement of dividend payment:
Supplementary material development:
None
Financial results meeting:None(Amounts less than one million yen are rounded down)(The number with parenthesis shows negative figure)1. Consolidated financial results for the First quarter of the year ending March 31st, 2022 (April 1st, 2021 throughJune 30th, 2021)(1) Consolidated operating results (cumulative)(% represents increases or decreases from the previous year)
Ordinary
Profit attributable to
Net sales
Operating Profit
Profitowners of parent
millionmillionmillionmillion
%
%
%
%
yen
yen
yen
yen
First quarter of the year
27,587
4,195
79.5
4,317
77.6
2,771
58.5
ending March 31st, 2022
First quarter of the year
27,297
(4.5)
2,337
(9.9)
2,431
(7.3)
1,749
(5.7)
ended March 31st, 2021
(Note) Comprehensive income
First quarter of the year ending March 31st, 2022:2,589 million yen / 16.2 %First quarter of the year ended March 31st, 2021: 2,227 million yen / 33.2 %The “Accounting Standards for Revenue Recognition” (ASBJ Statement No. 29, March 31 st, 2020), etc. has
been applied since the beginning of the first quarter of the current consolidated fiscal year. The percentage ofyear-on-year change for “Net Sales” is not indicated as the figures for the first quarter is calculated after theapplication of the said Accounting Standard. (The figures for “Operating Profit”, “Ordinary Profit”, and“Profit attributable to owners of parent” have not been affected by the said Accounting Standard.).
A consolidated “Net Sales” reaches 29,489 million yen (up 8.0% year-on-year basis) if not applied the said
Accounting Standards.
Earnings
per shareyen

Diluted earnings
per shareyen

183.31―115.69―First quarter of the year
ending March 31st, 2022
First quarter of the year
ended March 31st, 2021
(2) Consolidated financial situation

Total assets
First quarter of the year
ending March 31st, 2022
Year ended March 31st,
2021

Net assets

Shareholders'equity ratio

Net assets
per share

million yen

million yen%

yen

182,047

137,52275.5

9,095.48

191,762

137,98172.0

9,125.88- 1 -(Reference) Shareholders' equity:
First quarter of the year ending March 31st, 2022: 137,522 million yen
Fiscal year ended March 31st, 2021: 137,981 million yen
2. Dividends
Annual Dividends per share
End of the
End of the
End of the term
second quarter
third quarter
yen
yen
yen

End of thefirst quarteryen

Annualyen
Year ended
March 31st,
―
75.00
―
200.00275.002021
Year ending
March 31st,―
2022
Year ending
March 31st,
100.00―115.00215.002022 (forecast)(Note) Revisions to recent dividend forecast: Yes
The detail of second quarter dividend of Year ended March 31st, 2021; ordinary dividend 55.00 yen, extra
dividend 20.00 yen
The detail of year-end dividend of Year ended March 31st, 2021; ordinary dividend 90.00 yen, extra dividend
110.00 yen
The detail of second quarter dividend of Year ending March 31st, 2022 (forecast); ordinary dividend 80.00 yen,
extra dividend 20.00 yen
The detail of year-end dividend of Year ending March 31st, 2022 (forecast); ordinary dividend 80.00 yen, extra
dividend 35.00 yen
3. Forecast of consolidated financial results for fiscal year ending March 31st, 2022 (April 1st, 2021 throughMarch 31st, 2022)(% represents increase or decrease from the previous year)

Net sales

Full-year

Operating Profit

Ordinary Profit

millionyen%

millionyen%

millionyen%

125,000-

15,000(24.3)

15,000(26.0)

Profit attributableto owners ofparentmillion%yen
11,000Earnings
per share(25.3)

yen
727.52(Note) Revisions to recent business forecast: Yes
The “Accounting Standards for Revenue Recognition” (ASBJ Statement No. 29, March 31 st, 2020), etc. has
been applied since the beginning of the first quarter of the current consolidated fiscal year. The percentage ofyear-on-year change for “Net Sales” is not indicated as the figures for the first quarter is calculated after theapplication of the said Accounting Standard. (The figures for “Operating Profit”, “Ordinary Profit”, and“Profit attributable to owners of parent” have not been affected by the said Accounting Standard.).
*Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries involving changes inthe scope of consolidation): None
(2) Application of special accounting methods for the preparation of the consolidated quarterly financial
statements: None
(3) Changes in accounting policies, accounting projections and restatement(i) Changes in accounting policies associated with revision of accounting standards: Yes(ii) Changes other than (i) above: None

- 2 -(iii) Changes in accounting projections: None(iv) Restatement: None
Note: For details, please refer to Changes in Accounting Policy in (3) Notes to consolidated quarterly financial
statement on page 9.
(4) Number of outstanding shares (common shares)(i) Number of outstanding shares at the end of the period (including treasury shares)
First quarter of the year ending March 31st, 2022: 19,588,000 sharesYear ended March 31st, 2021: 19,588,000 shares(ii) Number of shares of treasury shares at the end of the period:First quarter of the year ending March 31st, 2022: 4,468,170 sharesYear ended March 31st, 2021: 4,468,250 shares(iii) Average number of shares during the period (accumulated consolidated quarter)
First quarter of the year ending March 31st, 2022: 15,119,815 sharesFirst quarter of the year ended March 31st, 2021: 15,119,088 shares* This summary is not subject to audit procedure.
* Explanation about the appropriate use of the forecasts of financial results, and other noteworthy matters
The projections and other statements with respect to the future included in this material are based on currently
available information and certain assumptions that are judged reasonable by Fukuda Denshi (hereinafter “theGroup”). Please be advised that the Group does not guarantee in any way the achievement of the projections
and other goals in this material and that cases may occur where the actual results and other situations differ
materially from the projections due to various factors. With respect to the preconditions for the forecast offinancial results, please refer to “(3) Explanation about consolidated earnings forecast” under the “1.
Qualitative information about consolidated earnings results for the quarter under review" section on page 5.

- 3 -Contents of the Attached Materials
1. Qualitative information about consolidated earnings results for the quarter under review--------

P.05(1) Explanation about consolidated operating results-----------------------------------------------------

P.05(2) Explanation about consolidated financial situation---------------------------------------------------

P.05(3) Explanation about consolidated earnings forecast----------------------------------------------------

P.05

2. Consolidated quarterly financial statements and Notes-------------------------------------------------

P.06------------------------------------------------------------------

P.06(2) Consolidated quarterly income statements and consolidated quarterly comprehensive income
statements

P.08(1) Consolidated quarterly balance sheets

Consolidated quarterly income statements
First quarter of the consolidated term----------------------------------------------------------------

P.08

Consolidated quarterly comprehensive income statements
First quarter of the consolidated term----------------------------------------------------------------(3) Notes to consolidated quarterly financial statement(Notes regarding the premise for going concern)--------------------------------------------------

P.09--------------------------------------------------------

P.09(Notes when there is a significant fluctuation in the amount of shareholders’ equity)(Changes in Accounting Policy)

P.09-------------

P.09---------------------------------------------------------------------------

P.09

- 4 -

1. Qualitative information about consolidated earnings results for the quarter under review(1) Explanation about consolidated operating results
The Japanese economy during the consolidated cumulative first quarter of this fiscal year (April 1 st,
2021 through March 31st, 2022) has been in severe conditions due to the continued impact of the
COVID-19 pandemic. The economic prospects remain uncertain for the time being even though somesigns of recovery have been showed.
In the medical device industry, the remuneration for medical treatments in FY2020 has been a positive
revision as a whole. However, medical institutions are still facing huge COVID-19 burden.
In such an environment, the Group posted a consolidated “Net sales” of 27,587 million yen,
“Operating profit” of 4,195 million yen (up 79.5% year-on-year basis), “Ordinary profit” of 4,317
million yen (up 77.6% year-on-year basis), and “Profit attributable to owners of parent” of 2,771 million
yen (up 58.5% year-on-year basis) in the first quarter.
The “Accounting Standards for Revenue Recognition” (ASBJ Statement No. 29, March 31 st, 2020),
etc. has been applied since the beginning of the first quarter of the current consolidated fiscal year. The
percentage of year-on-year change for “Net Sales” is not indicated as the figures for the first quarter iscalculated after the application of the said Accounting Standard. (The figures for “Operating Profit”,“Ordinary Profit”, and “Profit attributable to owners of parent” have not been affected by the said
Accounting Standard.)
A. Physiological diagnostic equipment segment
While the sales of electrocardiographs increased, the number of large orders has decreased. As aresult, consolidated “Net sales” were 5,013 million yen.
B. Patient monitoring equipment segment
Consolidated “Net sales” of patient monitoring equipment were 2,551 million yen.
C.

Medical treatment equipment segment
The sales of AEDs, pacemakers, and the business of renting medical equipment for home treatment
increased. As a result, consolidated “Net sales” were 12,660 million yen.

D.

Consumables and other products segment
In this segment, we mainly handle recording paper, disposable electrodes, and consumables used for
devices handled in the above segments, as well as maintenance and repair services.
Consolidated “Net sales” for this segment were 7,361 million yen.

(2) Explanation about consolidated financial situation“Total assets” decreased 9,715 million yen from the end of previous fiscal year to reach 182,047 million
yen. The main factors are the decrease of 13,914 million yen in “Notes and accounts receivable - trade”
despite the increase of 1,830 million yen in “Merchandise and finished goods” and 3,437 million yen in“Property, plant and equipment”.
“Total liabilities” decreased 9,256 million yen from the end of the previous fiscal year to reach 44,525
million yen. The main factor is the decrease of 5,115 million yen in “Notes and accounts payable - trade”
and 4,145 million yen in “Income taxes payable”.
“Net assets” decreased 458 million yen from the end of the previous fiscal year to reach 137,522 million
yen. The main factor is the decrease of 276 million yen in “Retained earnings” and 226 million yen in“Valuation difference on available-for-sale securities”.
(3) Explanation about consolidated earnings forecast
For the information about consolidated earnings forecast, please refer to the announcement posted on
July 30th “Notice of the Forecast of the Financial Results and Dividends for the Fiscal Year Ending March2022”.

- 5 -2. Consolidated quarterly financial statements and Notes(1) Consolidated quarterly balance sheets
Previous fiscal year
(as of March 31st, 2021)
AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade
Electronically recorded monetaryclaims - operating
Securities
Merchandise and finished goods
Work in process
Raw materials and supplies
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant and equipment
Intangible assets
Investments and other assets
Investment securities
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets
Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations operating
Short-term borrowings
Income taxes payable
Provision for bonuses
Provision for product warranties
Other provisions
Other
Total current liabilities
Non-current liabilities
Retirement benefit liability
Other provisions
Other
Total non-current liabilities
Total liabilities- 6 -(Million yen)
End of the First quarter
under review(as of June 30th, 2021)

56,59043,16155,05029,247

2,799

3,126

1,483
9,792
123
2,920
1,848
(57)
118,663

937
11,622
303
3,847
2,151
(32)
106,253

40,778
1,584

44,215
1,506

10,051
20,696(12)
30,73573,099191,762

9,728
20,354(12)
30,07075,793
182,047

20,27315,157

9,166

8,683

1,750
4,887
3,193
70
436
7,321
47,098

1,750
741
1,222
70
116
10,09937,842

3,193
401
3,088
6,683
53,781

3,212
411
3,059
6,683
44,525

Previous fiscal year
(as of March 31st, 2021)
Net assets
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders' equity
Accumulated other comprehensive
incomeValuation difference on
available-for-sale securities
Foreign currency translation
adjustment
Remeasurements of defined benefit
plans
Total accumulated othercomprehensive income
Total net assets
Total liabilities and net assets- 7 -(Million yen)
End of the First quarter
under review(as of June 30th, 2021)

4,621
21,841
130,491(20,378)
136,575

4,621
21,841
130,214(20,378)
136,299

1,805

1,579

(274)

(240)

(125)

(115)

1,405

1,222

137,981
191,762

137,522
182,047

(2) Consolidated quarterly income statements and consolidated quarterly comprehensive income statements
Consolidated quarterly income statements(First quarter of the consolidated term)

Net sales
Cost of sales
Gross profit
Selling, general and administrative
expenses
Operating profit
Non-operating income
Interest income
Dividend income
Foreign exchange gains
Gain on investments in investment
partnership
Other
Total non-operating income
Non-operating expenses
Interest expenses
Foreign exchange losses
Loss on investments in investment
partnership
Other
Total non-operating expenses
Ordinary profit
Extraordinary income
Gain on sales of non-current assets
Gain on sales of investment securities
Surrender value of insurance policies
Total extraordinary income
Extraordinary losses
Loss on sales of non-current assets
Impairment loss
Loss on valuation of investment
securities
Office relocation expenses
Loss on cancellation of insurance
policies
Total extraordinary losses
Profit before income taxes
Income taxes - current
Income taxes - deferred
Total income taxes
ProfitProfit attributable to owners of parent

First quarter of theprevious consolidated term(from April 1st, 2020
to June 30th, 2020)
27,297
14,98912,308(Million yen)First quarter of theconsolidated term(from April 1st, 2021
to June 30th, 2021)
27,587
13,244
14,343

9,970

10,147

2,337

4,195

15
67
-

17
54
6

-

78

34
116

22
178

9
9

9
-

-

42

3
22
2,431

5
57
4,317

0
253
58
313

1
60
62

1
0

6

251

-

-

0

-

24

253
2,491
901
(158)
742
1,749
1,749

31
4,347
1,475
101
1,576
2,771
2,771

- 8 -

Consolidated quarterly comprehensive income statements(First quarter of the consolidated term)

ProfitOther comprehensive income
Valuation difference on
available-for-sale securities
Foreign currency translation
adjustment
Remeasurements of defined benefit
plans, net of tax
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable toowners of parent

First quarter of theprevious consolidated term(from April 1st, 2020
to June 30th, 2020)
1,749(Million yen)First quarter of theconsolidated term(from April 1st, 2021
to June 30th, 2021)
2,771

482

(226)

(27)

33

23

10

478
2,227

(182)
2,589

2,227

2,589

(3) Notes to consolidated quarterly financial statement(Notes regarding the premise for going concern)
Not applicable.
(Notes when there is a significant fluctuation in the amount of shareholders’ equity)
Not applicable.
(Changes in Accounting Policy)
Application of the Accounting Standard for Revenue Recognition, etc.
The “Accounting Standards for Revenue Recognition” (ASBJ Statement No. 29, March 31 st, 2020.
Hereinafter, “Accounting Standard for Revenue Recognition”), etc. has been applied since the beginning of
the first quarter of the current consolidated fiscal year. In accordance with this accounting standard, the Group
recognizes revenue as the amount expected to be received in exchange for the promised goods orservices when the control of the goods or services is transferred to the customer.
Revenue Recognition in terms of agent transaction
Since the beginning of the first quarter of the current consolidated fiscal year, the Group recognizes revenue
as the net amount received from the customer after deduction of the payment for the suppliers in terms of theagent transaction.
The application of the Accounting Standard for Revenue Recognition is pursuant to the transitional
treatment stipulated in the proviso of Paragraph 84 of the Accounting Standard for Revenue Recognition.
The cumulative effect when applying the new accounting policy retrospectively from before the beginningof the first quarter of the current consolidated fiscal year is added to or subtracted from the retained
earnings at the beginning of the first quarter of the current consolidated fiscal year before applying the new
accounting policy from the beginning-of-year balance.
As a result, “Net sales” and “Cost of sales” each decreased 1,901 million yen in the first quarter.
Application of Accounting Standard for Fair Value Measurement, etc.
The “Accounting Standard for Fair Value Measurement” (ASBJ Statement No. 30, July 4 th, 2019), etc.
have been applied since the beginning of the first quarter of the current consolidated fiscal year. In
accordance with the transitional treatment prescribed in Paragraph 19 of the “Accounting Standard for Fair
Value Measurement” and Paragraph 44–2 of the “Accounting Standard for Financial Instruments” (ASBJ
Statement No. 10, July 4th, 2019), the Group has decided to apply the new accounting policies set forth
by the Accounting Standard for Fair Value Measurement, etc. in the future.
These changes had no impact on the Group’s consolidated financial statements.

- 9 -* This English translation is for reference purposes only. The original Japanese version will prevail as the official
authoritative version.

- 10 -